SAN DIEGO, April 20 A new report from KLAS, an independent health care vendor research firm, concluded the CareFusion (NYSE: CFN) Alaris® System is one of the "best all-around" infusion pump options ...

BD is recalling hundreds of thousands of its Alaris infusion pumps and vital sign monitors due to multiple system faults, including software- and user-related issues. According to the FDA, the errors ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...

PEORIA — On any given day, nurses provide compassionate, and, often, life-saving care to their patients. Sometimes that care can have a worldwide impact because of how health care — and those who work ...

This technological achievement takes patient care and safety to a new level. ATLANTA, March 21, 2017 /PRNewswire-USNewswire/ -- Grady is proud to be Metro Atlanta's first hospital to successfully ...

CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).

Feb 6 (Reuters) - Cardinal Health Inc. said it reached an agreement with the U.S. Food and Drug Administration on a consent decree regarding its Alaris infusion pumps. The agreement, which is subject ...

Cardinal Health Inc. expects to drop another $20 million fixing a new problem in its flagship line of drug infusion pumps. The Dublin health products company said March 12 that it was withholding ...